Authors

  • Mirzoulug'bek Tojiddinov

DOI:

https://doi.org/10.71337/inlibrary.uz.science-research.73350

Keywords:

Campylobacter pyloridis gastrin-producing cells eradication metaplasia dysplasia gastric adenocarcinoma.

Abstract

Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that inhabits the stomach lining of many individuals worldwide. Over the years, it has been strongly associated with a number of gastrointestinal disorders, including duodenal ulcers, gastric ulcers, and gastric cancer. The historical journey of the understanding of H. pylori and its role in gastric diseases has transformed medical knowledge, leading to new methods of diagnosis, treatment, and prevention. This article delves into the history of Helicobacter pylori, its connection to peptic ulcers, and its role in the development of gastric cancer.

background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

687

THE HISTORY OF HELICOBACTER PYLORI, DUODENAL ULCER, GASTRIC

ULCER, AND GASTRIC CANCER

Tojiddinov Mirzoulug'bek Avazbek o'g'li

Teacher of Kokand University Andijan branch in Uzbekistan

https://doi.org/10.5281/zenodo.15082523

Introduction

Abstract.

Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that inhabits the

stomach lining of many individuals worldwide. Over the years, it has been strongly associated

with a number of gastrointestinal disorders, including duodenal ulcers, gastric ulcers, and gastric

cancer. The historical journey of the understanding of H. pylori and its role in gastric diseases

has transformed medical knowledge, leading to new methods of diagnosis, treatment, and

prevention. This article delves into the history of Helicobacter pylori, its connection to peptic

ulcers, and its role in the development of gastric cancer.

Keywords:

Campylobacter pyloridis,

gastrin-producing cells, eradication, metaplasia,

dysplasia, gastric adenocarcinoma.

ИСТОРИЯ HELICOBACTER PYLORI, ЯЗВЫ ДВЕНАДЦАТИПЕРСТНОЙ КИШКИ,

ЯЗВЫ ЖЕЛУДКА И РАКА ЖЕЛУДКА

Аннотация.

Helicobacter pylori (H. pylori) — спиралевидная бактерия, обитающая

в слизистой оболочке желудка многих людей по всему миру. На протяжении многих лет

она тесно связана с рядом желудочно-кишечных расстройств, включая язву

двенадцатиперстной кишки, язву желудка и рак желудка.

Исторический путь понимания H. pylori и ее роли в желудочных заболеваниях

изменил медицинские знания, что привело к появлению новых методов диагностики,

лечения и профилактики. В этой статье рассматривается история Helicobacter pylori, ее

связь с пептическими язвами и ее роль в развитии рака желудка.

Ключевые слова:

Campylobacter pyloridis, клетки, продуцирующие гастрин,

эрадикация, метаплазия, дисплазия, аденокарцинома желудка.

The Discovery of Helicobacter pylori

The story of Helicobacter pylori began in the early 1980s when two Australian researchers,

Barry Marshall

and

Robin Warren

, made a groundbreaking discovery.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

688

Before this, the prevailing medical belief was that peptic ulcers (which include both

duodenal and gastric ulcers) were caused primarily by stress, spicy foods, or an excess of stomach

acid.

In 1982, Marshall and Warren isolated a previously unknown bacterium from the stomach

lining of patients suffering from chronic gastritis and peptic ulcers. They identified this bacterium

as

Campylobacter pyloridis

(later renamed Helicobacter pylori due to its unique shape and

characteristics). The researchers noted that the bacterium was found in the stomach of nearly all

patients with gastritis and ulcers.

Barry Marshall famously drank a culture of H. pylori to prove that the bacterium could

cause gastritis and lead to peptic ulcers. Within days, he developed symptoms of gastritis, which

further solidified the link between H. pylori and ulcer formation.

For this pioneering work, Marshall and Warren were awarded the

Nobel Prize in

Physiology or Medicine

in 2005, a recognition that forever changed the understanding of

gastrointestinal diseases.

1.

The Discovery of Helicobacter pylori and Duodenal Ulcers

The connection between

Helicobacter pylori

and

duodenal ulcers

represents one of the

most important breakthroughs in gastroenterology over the past few decades. Before the discovery

of

H. pylori

, the causes of

duodenal ulcers

were largely attributed to factors such as stress, diet,

excessive acid production, and lifestyle. However, in the early 1980s, a groundbreaking discovery

by

Barry Marshall

and

Robin Warren

completely revolutionized the understanding of ulcer

formation, particularly in relation to the

duodenum

.

2.

The Pioneering Discovery by Barry Marshall and Robin Warren

The story of

Helicobacter pylori

begins in 1982 when

Robin Warren

, an Australian

pathologist, first observed that

H. pylori

, a spiral-shaped bacterium, was consistently found in the

stomach lining of patients with chronic gastritis and duodenal ulcers. Warren initially noted this

during routine examination of biopsy samples taken from patients with stomach complaints. His

observations suggested that

H. pylori

was often present in these patients, but it wasn’t immediately

clear what role the bacterium played in the ulcerative process.

At the time,

duodenal ulcers

were primarily attributed to

excessive stomach acid

or

lifestyle factors such as smoking, stress, and poor diet. The prevailing theory was that an imbalance

in gastric acid production led to ulcer formation, with little consideration for infectious causes.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

689

3.

Barry Marshall's Self-Experiment and Confirmation of the Theory

While Warren was unsure about the causative role of

H. pylori

,

Barry Marshall

, a young

physician working in the same department, became increasingly convinced that the bacterium

might be the key factor. Marshall hypothesized that

H. pylori

could be responsible for not just

gastritis but also for causing

peptic ulcers

, including

duodenal ulcers

.

To prove his theory, Marshall decided to take the drastic step of drinking a culture of

H.

pylori

himself. In doing so, he hoped to induce an infection and demonstrate the bacterium’s role

in ulcer development. After drinking the culture, Marshall developed symptoms of

gastritis

, which

were confirmed by endoscopic examination. He showed that

H. pylori

could cause inflammation

in the stomach and duodenum, supporting the idea that the bacterium was indeed the primary cause

of ulcers.

Marshall and Warren's research ultimately led to the conclusion that

H. pylori

infection

was a major cause of both

gastric

and

duodenal ulcers

. Their discovery turned the prevailing

view of ulcers on its head, shifting the focus from lifestyle factors and stomach acid alone to an

infectious origin.

4.

Nobel Prize and Recognition

In recognition of their groundbreaking work, Marshall and Warren were awarded the

Nobel

Prize in Physiology or Medicine

in

2005

. Their discovery had profound implications for the

treatment of ulcers and significantly advanced the field of gastroenterology. The work also

changed the way doctors approached the treatment of

duodenal ulcers

, leading to more effective

therapies based on eradicating the bacterial infection rather than just reducing stomach acid.

5.

The Role of Helicobacter pylori in Duodenal Ulcers

The mechanism by which

H. pylori

causes

duodenal ulcers

involves several key steps:

1.

Invasion of the Mucosal Lining

:

H. pylori

survives the acidic environment of the stomach by producing

urease

, an

enzyme that neutralizes stomach acid. This allows the bacterium to colonize the mucosal lining of

the stomach and duodenum. The bacterium's spiral shape helps it burrow into the protective mucus

layer of the stomach lining.

2.

Induction of Inflammation

:

Once

H. pylori

attaches to the stomach and duodenal lining, it triggers an immune

response. The div's immune system sends inflammatory cells (such as

neutrophils

and

macrophages

) to the site of infection, which results in chronic inflammation of the stomach and


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

690

duodenum (gastritis and duodenitis). This inflammation weakens the mucosal barrier, making it

more vulnerable to the effects of stomach acid.

3.

Damage to the Mucosal Barrier

:

The bacteria release toxins (such as

CagA

and

VacA

) that contribute to mucosal

damage. This damage to the protective mucus layer makes the duodenal lining more susceptible

to the corrosive effects of gastric acid, which can ultimately lead to the formation of an ulcer.

4.

Increased Acid Production

:

H. pylori

infection can also stimulate the stomach to produce more acid. In some

cases, the bacterium affects the

gastrin-producing cells

in the stomach, increasing acid secretion.

This higher acid production contributes to the injury of the duodenum, exacerbating the ulcerative

process.

5.

Gastric Motility Changes

:

H. pylori

may also affect gastric motility, slowing the emptying of food from the

stomach into the duodenum. This delay can increase the exposure of the duodenal lining to

stomach acid, which is a contributing factor to ulcer formation.

How Helicobacter pylori Causes Duodenal Ulcers

The development of

duodenal ulcers

due to

H. pylori

infection involves several key

mechanisms:

1.

Infection of the Stomach and Duodenal Lining

:

H. pylori

is a bacterium that thrives in the acidic environment of the stomach. It

attaches to the

gastric mucosa

(stomach lining) and can also affect the duodenum. The bacterium

produces an enzyme called

urease

, which neutralizes stomach acid, creating a more favorable

environment for the bacterium.

2.

Chronic Inflammation

:

H. pylori

infection triggers a chronic

inflammatory response

in the stomach and

duodenum. The div’s immune system sends inflammatory cells to the infected area, which leads

to ongoing tissue damage. Over time, this chronic inflammation can weaken the mucosal barrier

that protects the stomach and duodenal lining from stomach acid, making the lining more

susceptible to damage.

3.

Disruption of the Mucosal Barrier

:

The duodenum and stomach are lined with a protective mucus layer that shields the

tissue from the corrosive effects of stomach acid.

H. pylori

damages this protective layer. As the


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

691

infection continues, the duodenum becomes more vulnerable to the digestive effects of gastric

acid. This damage can result in the formation of ulcers.

4.

Increased Acid Production

:

H. pylori

infection can lead to

increased acid production

in the stomach. The

bacterium's ability to alter gastric function and increase acid secretion is thought to contribute to

the formation of ulcers, especially in the duodenum, where the mucosal lining is thinner and more

sensitive to acidic injury.

5.

Virulence Factors of H. pylori

:

Some strains of

H. pylori

, such as those with the

CagA gene

(Cytotoxin-associated gene

A), are more virulent and more strongly associated with duodenal ulcers. These strains cause more

aggressive inflammation and can lead to greater damage to the mucosal lining, increasing the

likelihood of ulcer formation.

Epidemiology and Prevalence of H. pylori in Duodenal Ulcers

Helicobacter pylori

is found in about

80-90%

of individuals with

duodenal ulcers

,

making it the primary cause of the condition. In populations with high rates of

H. pylori

infection,

such as in parts of

Asia

,

Africa

, and

Latin America

, the prevalence of

duodenal ulcers

is also

high.

However, not all individuals infected with

H. pylori

will develop ulcers. This suggests that

additional factors, such as genetic susceptibility, lifestyle choices (e.g., smoking, alcohol

consumption), and the specific strain of

H. pylori

present, contribute to the development of

duodenal ulcers.

The Link Between Helicobacter pylori and Gastric Ulcers

Helicobacter pylori

is a spiral-shaped bacterium that has long been associated with various

gastrointestinal disorders, including

gastric ulcers

. Gastric ulcers are open sores or lesions that

develop on the lining of the stomach, causing pain and discomfort, particularly after eating. For

many years, the cause of gastric ulcers was widely believed to be linked to stress, spicy foods, or

excessive stomach acid. However, the discovery of

H. pylori

in the early 1980s revolutionized the

understanding of this condition.

Discovery of Helicobacter pylori and Its Role in Gastric Ulcers

The discovery of

Helicobacter pylori

by

Barry Marshall

and

Robin Warren

in 1982

marked a turning point in the field of gastroenterology. Prior to this, ulcers were thought to be the

result of lifestyle factors, such as stress, smoking, or a high-fat diet.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

692

However, Marshall and Warren showed that

H. pylori

was present in the stomach lining

of patients with chronic gastritis and ulcers, and their studies demonstrated that the bacterium

could cause inflammation and damage to the stomach’s protective mucus layer.

Barry Marshall's

famous self-experiment, where he drank a culture of

H. pylori

and

developed gastritis, helped confirm the bacterium's role in causing ulcers. For their work, Marshall

and Warren were awarded the

Nobel Prize in Physiology or Medicine

in 2005.

How H. pylori Causes Gastric Ulcers

The development of

gastric ulcers

is strongly linked to the chronic infection of the stomach

lining by

H. pylori

. The bacterium disrupts the stomach's mucosal defense mechanisms, leading

to ulcer formation. Here’s how the infection leads to the development of gastric ulcers:

1.

Invasion of the Stomach Lining

:

H. pylori

infects the stomach lining and attaches itself to the epithelial cells of the

stomach. It is uniquely adapted to survive in the harsh acidic environment of the stomach, where

most bacteria would be killed.

2.

Inflammatory Response

:

Once

H. pylori

colonizes the stomach lining, it induces a chronic

inflammatory

response

. The div's immune system reacts to the bacteria by producing various immune

molecules, including

cytokines

and

chemokines

, which recruit white blood cells to the site of

infection.

This chronic inflammation leads to damage to the stomach lining over time.

3.

Damage to the Mucosal Barrier

:

The stomach lining has a protective layer of mucus that shields the underlying cells

from stomach acid.

H. pylori

damages this protective barrier by releasing

urease

, an enzyme that

converts urea into ammonia. Ammonia neutralizes stomach acid, allowing the bacteria to survive,

but this also weakens the mucosal barrier, making it more susceptible to damage from the acidic

environment.

4.

Increased Acid Production

:

H. pylori

infection can stimulate the

gastric acid secretion

process, further

damaging the stomach lining. The increased acid production leads to erosion of the mucosal lining,

which can eventually result in ulcer formation.

5.

Toxins Produced by H. pylori

:


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

693

Certain strains of

H. pylori

produce

vacA

(vacuolating cytotoxin A) and

CagA

(Cytotoxin-associated gene A) proteins. These toxins damage the stomach lining and lead to the

development of ulcers. The

CagA-positive strains

are considered more virulent and are associated

with an increased risk of gastric ulcers and gastric cancer.

Epidemiology and Prevalence of H. pylori in Gastric Ulcers

Studies have shown that

H. pylori

infection is present in the majority of patients with

gastric ulcers

. It is estimated that approximately

70-90%

of patients with gastric ulcers have

H.

pylori

infection. The bacterium is more prevalent in populations with lower socioeconomic status,

particularly in areas with poor sanitation and overcrowding.

The infection is usually acquired in childhood and can persist for decades if left untreated.

In fact, untreated

H. pylori

infection is a major risk factor for the recurrence of gastric ulcers. It is

particularly common in regions of the world where the bacterium is widespread, such as in parts

of

Asia

,

Africa

, and

Latin America

.

Gastric Cancer: The Role of Helicobacter pylori

Gastric cancer (GC), also known as stomach cancer, is one of the most common and deadly

cancers globally, particularly in regions such as East Asia, Eastern Europe, and South America.

Over the years, extensive research has established a significant link between

Helicobacter pylori

(H. pylori)

infection and the development of gastric cancer. This section explores the historical

background, mechanisms, and current understanding of how H. pylori contributes to the onset of

gastric cancer.

Historical Context

The connection between

Helicobacter pylori

and gastric cancer has evolved over the

years. In the early 1990s,

H. pylori

was initially recognized as a causative agent of

gastritis

and

peptic ulcers

. However, by the mid-1990s, research began to suggest that chronic infection with

the bacterium could lead to more severe complications, including

gastric cancer

.

In 1994, the

World Health Organization (WHO)

classified

H. pylori

as a

Group 1

carcinogen

(the highest risk category), recognizing its critical role in the development of gastric

cancer. This classification was based on a growing div of evidence linking

long-term H. pylori

infection to both

gastritis

and

gastric cancer

, particularly

gastric adenocarcinoma

.

1.

Mechanisms by Which H. pylori Contributes to Gastric Cancer

The exact mechanisms by which

H. pylori

induces gastric cancer are complex and involve

several factors:


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

694

2.

Chronic Inflammation

:

The most established mechanism involves

chronic inflammation

. H. pylori infection

induces a persistent inflammatory response in the stomach lining. The immune system's response

to the bacterium leads to the release of pro-inflammatory cytokines and other molecules that cause

long-term damage to the gastric mucosa.

This chronic inflammation is thought to be a key factor in the development of

precancerous lesions

such as

intestinal metaplasia

,

dysplasia

, and ultimately

gastric

adenocarcinoma

.

2.

Alteration of Gastric Environment

:

H. pylori infection disrupts the balance of the stomach’s

microbiome

and alters the acid-

producing cells in the gastric lining. In response to the infection, the stomach may produce more

acid, leading to further damage of the mucosal lining.

Some strains of

H. pylori

carry the

CagA gene

(Cytotoxin-associated gene A), which is

associated with a more aggressive form of infection. The CagA protein is believed to directly

interact with the host cell's signaling pathways, inducing changes in cellular function that may

promote cancerous transformation.

3.

DNA Damage and Mutagenesis

:

Long-term H. pylori infection has been shown to cause

DNA damage

in gastric epithelial

cells. The bacterium produces various

toxins

, such as

vacA

(vacuolating cytotoxin A), which can

cause cellular injury and stress, promoting genetic mutations in the host cells.

These mutations can accumulate over time, leading to the formation of

precancerous lesions

and eventually

gastric cancer

.

4.

Increased Risk of Helicobacter pylori-Induced Gastric Cancer

:

Certain factors increase the risk of

gastric cancer

in individuals infected with

H. pylori

,

including:

Strain virulence

: Some strains of H. pylori, such as those that possess the

CagA gene

,

are more likely to cause severe disease and are strongly linked to gastric cancer.

Chronicity of infection

: Long-term, untreated infection increases the likelihood of

developing precancerous changes in the stomach lining.

Environmental and lifestyle factors

: Diet (e.g., high salt intake, smoking, and alcohol

consumption) and genetic factors can exacerbate the carcinogenic effects of

H. pylori

infection.

Epidemiological Evidence Linking H. pylori to Gastric Cancer


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

695

Numerous large-scale epidemiological studies and clinical trials have demonstrated the

relationship between

H. pylori infection

and

gastric cancer

:

A landmark study by

Uemura et al.

(2001) found that individuals infected with

H. pylori

had a significantly higher risk of developing gastric cancer compared to those without infection.

The study highlighted that the eradication of

H. pylori

could reduce the incidence of gastric cancer

in high-risk populations.

Another study published by

Correa et al.

(1990) demonstrated that

chronic H. pylori

infection

is a central factor in the development of

intestinal-type gastric cancer

, which is the

most common form of gastric cancer.

Global studies

have also shown that populations with high rates of

H. pylori infection

,

such as in parts of

China

,

Japan

, and

South Korea

, also have high incidence rates of gastric

cancer. This correlation is especially strong in countries where

gastric cancer

remains a leading

cause of cancer-related deaths.

Prevention and Eradication of H. pylori as a Strategy for Gastric Cancer Prevention

Given the established role of

H. pylori

in gastric cancer, efforts have been made to explore

its eradication as a means of preventing the disease.

1.

Helicobacter pylori Eradication Therapy

:

The standard approach to

H. pylori eradication

involves a combination of antibiotics

(such as

clarithromycin

,

amoxicillin

, and

metronidazole

) and

proton pump inhibitors (PPIs)

to reduce stomach acid. This regimen is highly effective in eliminating the bacterium from the

stomach.

For individuals at high risk of gastric cancer, particularly those with

intestinal

metaplasia

or a family history of gastric cancer, early eradication therapy may help reduce the

long-term risk of developing cancer.

2.

Screening and Early Detection

:

In regions with a high incidence of gastric cancer,

H. pylori screening

is often

recommended, particularly for individuals over 50. Early detection and treatment of

H. pylori

infection may prevent the development of cancerous changes in the gastric mucosa.

Endoscopy

and

biopsy

remain key diagnostic tools for detecting precancerous lesions,

although non-invasive tests like the

urea breath test

and

stool antigen test

are becoming more

widely used.

3.

Vaccination

:


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

696

Although

vaccines

for

H. pylori

are still under development, the idea of

preventing H.

pylori infection

via vaccination is being actively researched. A successful vaccine would not only

reduce the incidence of peptic ulcers but also potentially lower the global burden of gastric cancer.

Advances in Diagnosis and Treatment

The understanding of Helicobacter pylori's role in peptic ulcers and gastric cancer has

prompted major advancements in diagnosis and treatment. Initially, diagnosing H. pylori infection

involved invasive methods such as

endoscopy

and

biopsy

. However, less invasive tests have since

been developed, including

urea breath tests

,

stool antigen tests

, and

serologic tests

. These

methods have made it easier for doctors to detect the bacterium in patients.

Treatment for H. pylori infection generally consists of a combination of antibiotics (such

as clarithromycin, amoxicillin, and metronidazole) and acid-suppressing medications (like proton

pump inhibitors or H2 blockers). This approach, known as

triple therapy

or

quadruple therapy

,

has proven highly effective in eradicating the infection and healing ulcers.

In regions with high gastric cancer prevalence, some researchers are exploring the

possibility of using H. pylori eradication as a preventive measure against gastric cancer. Early

studies suggest that treating H. pylori infection may reduce the risk of developing gastric cancer,

especially when done before the appearance of precancerous lesions.

Conclusion

The history of Helicobacter pylori, duodenal ulcers, gastric ulcers, and gastric cancer has

dramatically changed over the past few decades. From the initial skepticism surrounding Marshall

and Warren's discovery of H. pylori, to the current understanding of its critical role in both peptic

ulcers and gastric cancer, the scientific community has made great strides in improving the

diagnosis, treatment, and prevention of these diseases.

As more research continues, we are likely to see further advancements in the management

of H. pylori infections, including more targeted therapies and potential vaccines. The

understanding of H. pylori’s role in gastrointestinal health continues to shape the future of

medicine, and its history remains a testament to the power of scientific discovery.

REFERENCES

1.

International Agency for Research on Cancer (IARC). (1994). "Helicobacter pylori: A major

cause of cancer."

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN SCIENCE АND RESEARCH»

VOLUME 4 / ISSUE 3 / UIF:8.2 / MODERNSCIENCE.UZ

697

2.

Malfertheiner, P., et al. (2017). "Management of Helicobacter pylori infection—The

Maastricht V/Florence Consensus Report."

Gut

.

3.

Sugano, K., et al. (2015). "Japan Gastric Cancer Guidelines 2014 (3rd edition)."

Journal of

Gastroenterology

.

4.

Uemura, N., et al. (2001). "Helicobacter pylori infection and the development of gastric

cancer."

New England Journal of Medicine

.

5.

Correa, P., & Haenszel, W. (1990). "A model for gastric cancer epidemiology."

Lancet

.

6.

Peterson, W. L., & Armstrong, D. (1997). "Helicobacter pylori and peptic ulcer disease."

New England Journal of Medicine

.

7.

Marshall, B., & Warren, J. R. (1984). "Unidentified curved bacilli in the gastric mucosa of

patients with gastritis and peptic ulceration."

The Lancet

.

8.

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 61:

Helicobacter pylori

and some other infectious agents (1994).

9.

National Cancer Institute (NCI). "Helicobacter pylori and Stomach Cancer." Available on

the NCI website.

10.

Nurgalieva, Z. et al. "Vaccines for Helicobacter pylori."

Vaccine

, 2017.

11.

PubMed

(www.pubmed.ncbi.nlm.nih.gov): A database of scientific research articles, where

you can find primary research studies and reviews on

H. pylori

and gastric cancer.

12.

Google Scholar

(scholar.google.com): An academic search engine that allows you to access

peer-reviewed research on this topic.

13.

National Cancer Institute (NCI)

: Visit the NCI website for information on the relationship

between

H. pylori

and gastric cancer.

NCI Website

14.

JAMA Network

(jamanetwork.com): A journal that frequently publishes studies on gastric

cancer and

H. pylori

.

References

International Agency for Research on Cancer (IARC). (1994). "Helicobacter pylori: A major cause of cancer." IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.

Malfertheiner, P., et al. (2017). "Management of Helicobacter pylori infection—The Maastricht V/Florence Consensus Report." Gut.

Sugano, K., et al. (2015). "Japan Gastric Cancer Guidelines 2014 (3rd edition)." Journal of Gastroenterology.

Uemura, N., et al. (2001). "Helicobacter pylori infection and the development of gastric cancer." New England Journal of Medicine.

Correa, P., & Haenszel, W. (1990). "A model for gastric cancer epidemiology." Lancet.

Peterson, W. L., & Armstrong, D. (1997). "Helicobacter pylori and peptic ulcer disease." New England Journal of Medicine.

Marshall, B., & Warren, J. R. (1984). "Unidentified curved bacilli in the gastric mucosa of patients with gastritis and peptic ulceration." The Lancet.

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 61: Helicobacter pylori and some other infectious agents (1994).

National Cancer Institute (NCI). "Helicobacter pylori and Stomach Cancer." Available on the NCI website.

Nurgalieva, Z. et al. "Vaccines for Helicobacter pylori." Vaccine, 2017.

PubMed (www.pubmed.ncbi.nlm.nih.gov): A database of scientific research articles, where you can find primary research studies and reviews on H. pylori and gastric cancer.

Google Scholar (scholar.google.com): An academic search engine that allows you to access peer-reviewed research on this topic.

National Cancer Institute (NCI): Visit the NCI website for information on the relationship between H. pylori and gastric cancer. NCI Website

JAMA Network (jamanetwork.com): A journal that frequently publishes studies on gastric cancer and H. pylori.